Aspirin for primary prevention of cardiovascular disease in women
For primary prevention, low-dose aspirin should be considered in women aged 40 to 70 years with a 10-year cardiovascular risk of 20% or more or in women with diabetes and a 10-year cardiovascular risk of 10% or more. The risk of bleeding outweighs the benefits in low-risk women and in women aged 70 years and older.
Source: Menopause - Category: OBGYN Tags: Clinical Corner: NAMS Practice Pearl Source Type: research
More News: Aspirin | Bleeding | Cardiology | Cardiovascular | Diabetes | Endocrinology | Heart | Men | Menopause | OBGYN | Women